Home/Filings/4/0001493152-21-020758
4//SEC Filing

Nathanielsz James Andrew 4

Accession 0001493152-21-020758

CIK 0001517681other

Filed

Aug 19, 8:00 PM ET

Accepted

Aug 20, 6:15 AM ET

Size

6.3 KB

Accession

0001493152-21-020758

Insider Transaction Report

Form 4
Period: 2021-08-17
Nathanielsz James Andrew
DirectorChief Executive Officer10% Owner
Transactions
  • Award

    Common stock, par value $0.001

    2021-08-17+5,928,0005,928,004 total(indirect: By Trust)
  • Award

    Common stock, par value $0.001

    2021-08-17+2,800,0002,800,000 total(indirect: By Spouse)

Documents

1 file

Issuer

Propanc Biopharma, Inc.

CIK 0001517681

Entity typeother

Related Parties

1
  • filerCIK 0001554937

Filing Metadata

Form type
4
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 6:15 AM ET
Size
6.3 KB